A Multicenter Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension (PH) in Heart Failure with Preserved Ejection Fraction (HFpEF)
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to look at the effect of oral treprostinil on the 6 Minute Walk Distance (6MWD) compared to placebo in patients who have been diagnosed with pulmonary hypertension(PH) due to heart failure with preserved ejection fraction (HFpEF).
Description
The purpose of this study is to look at the effect of oral treprostinil on the 6 Minute Walk Distance (6MWD) compared to placebo in patients who have been diagnosed with pulmonary hypertension(PH) due to heart failure with preserved ejection fraction (HFpEF).
Details
| Condition | pulmonary hypertension |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX7772 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.